Interim Report 1 January - 30 September 2026: Strong growth and improved profitability in the third quarter
Cision•27/10/2026•03:00 ET
4
Key Highlights
- ➤Q3 net sales SEK 511.7 million, up 31.2% year on year
- ➤Q3 EBITA SEK 30.9 million, versus SEK 13.9 million previously
- ➤Q3 EBITA margin widened to 6.0%, highest quarterly level since 2023
- ➤Denmark sales rose 255.3% to SEK 152.8 million; EBITA reached SEK 23.7 million
- ➤Norway sales increased 1.8% to SEK 267.3 million; EBITA fell to SEK 12.0 million
Expert Statements
Bård Kristiansen, CEO & Managing Director of Dedicare
“Strong growth and significantly improved earnings characterised the third quarter.”
Bård Kristiansen, CEO & Managing Director of Dedicare
“The healthcare staffing market is showing signs of more stability, even if demand does remain hesitant and competition is intense.”
Bård Kristiansen, CEO & Managing Director of Dedicare
“We’re continuing to experience faintly positive market progress in Sweden.”
DedicareThird quarter 2026 • Net sales SEK 511.7 million (389.9)
• EBITA SEK 30.9 million (13.9), adjusted for non-recurring items SEK 34.4 million (13.9)
Get started
Create a free account to read the full story.